Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Prever

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancers|July 24, 2021
Targeting PI3K/AKT/mTOR Signaling Pathway in Breast CancerHuayi Li, Lorenzo Prever, Emilio Hirsch, et al.
Cell Reports|June 6, 2024
Linking phosphoinositide function to mitosisLorenzo Prever, Gabriele Squillero, Emilio Hirsch, et al.
Science Signaling|May 28, 2024
A connection between phosphatidylinositol 5-phosphate and the Hippo pathway to prevent epithelial-mesenchymal transition in cancerEmilio Hirsch, Emanuele Fantastico, Lorenzo Prever, et al.
Annual Review of Pharmacology and Toxicology|October 6, 2020
Preventing and Treating Anthracycline Cardiotoxicity: New InsightsKonrad Teodor Sawicki, Valentina Sala, Lorenzo Prever, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|October 13, 2025
Decoding class II PI3K signaling: From membrane identity to human diseaseRoberta Rubino, Gabriele Squillero, Lorenzo Prever, et al.
Vascular Pharmacology|July 10, 2024
PI3KC2α controls cardiac contractility through regulation of β2-adrenergic receptor recyclingSophie Cnudde, Theresa Brand, Julia Fender, et al.
Experimental Hematology & Oncology|August 10, 2023
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Experimental Hematology & Oncology|June 13, 2025
Correction: Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 31, 2022
Phosphoinositide Conversion Inactivates R-RAS and Drives Metastases in Breast CancerHuayi Li, Lorenzo Prever, Myriam Y Hsu, et al.
The Journal of Clinical Investigation|February 2, 2026
SH3BP5L triggers the RAB11A-regulated integrin recycling network implicated in breast cancer metastasisHuayi Li, Maria Chiara De Santis, Francesco A Tucci, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancers|July 24, 2021
Targeting PI3K/AKT/mTOR Signaling Pathway in Breast CancerHuayi Li, Lorenzo Prever, Emilio Hirsch, et al.
Cell Reports|June 6, 2024
Linking phosphoinositide function to mitosisLorenzo Prever, Gabriele Squillero, Emilio Hirsch, et al.
Science Signaling|May 28, 2024
A connection between phosphatidylinositol 5-phosphate and the Hippo pathway to prevent epithelial-mesenchymal transition in cancerEmilio Hirsch, Emanuele Fantastico, Lorenzo Prever, et al.
Annual Review of Pharmacology and Toxicology|October 6, 2020
Preventing and Treating Anthracycline Cardiotoxicity: New InsightsKonrad Teodor Sawicki, Valentina Sala, Lorenzo Prever, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|October 13, 2025
Decoding class II PI3K signaling: From membrane identity to human diseaseRoberta Rubino, Gabriele Squillero, Lorenzo Prever, et al.
Vascular Pharmacology|July 10, 2024
PI3KC2α controls cardiac contractility through regulation of β2-adrenergic receptor recyclingSophie Cnudde, Theresa Brand, Julia Fender, et al.
Experimental Hematology & Oncology|August 10, 2023
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Experimental Hematology & Oncology|June 13, 2025
Correction: Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 31, 2022
Phosphoinositide Conversion Inactivates R-RAS and Drives Metastases in Breast CancerHuayi Li, Lorenzo Prever, Myriam Y Hsu, et al.
The Journal of Clinical Investigation|February 2, 2026
SH3BP5L triggers the RAB11A-regulated integrin recycling network implicated in breast cancer metastasisHuayi Li, Maria Chiara De Santis, Francesco A Tucci, et al.
Pageof 2